INTELLIA THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number
INTELLIA THERAPEUTICS, INC. (NTLA) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of 6.42 million shares as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber · last filed 2026-08-06
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 6.42M shares.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 6.29M shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 5.20M shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number 5.24M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number |
|---|---|
| 2026-06-30 | 6.42M shares 10-Q · filed 2026-08-06 |
| 2026-03-31 | 6.29M shares 10-Q · filed 2026-05-11 |
| 2025-12-31 | 5.20M shares 10-Q · filed 2026-08-06 |
| 2025-09-30 | 5.24M shares 10-Q · filed 2025-11-06 |
| 2025-06-30 | 5.28M shares 10-Q · filed 2025-08-07 |
| 2025-03-31 | 5.53M shares 10-Q · filed 2025-05-08 |
| 2024-12-31 | 5.55M shares 10-K · filed 2026-02-26 |
| 2024-09-30 | 5.45M shares 10-Q · filed 2024-11-07 |
| 2024-06-30 | 5.37M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 5.69M shares 10-Q · filed 2024-05-09 |
| 2023-12-31 | 4.04M shares 10-K · filed 2025-02-27 |
| 2023-09-30 | 3.92M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 4.09M shares 10-Q · filed 2023-08-03 |
| 2023-03-31 | 4.05M shares 10-Q · filed 2023-05-04 |
| 2022-12-31 | 1.94M shares 10-K · filed 2024-02-22 |
| 2022-09-30 | 1.93M shares 10-Q · filed 2022-11-03 |
| 2022-06-30 | 1.64M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 1.36M shares 10-Q · filed 2022-05-05 |
| 2021-12-31 | 453.03K shares 10-K · filed 2023-02-23 |
| 2021-09-30 | 443.29K shares 10-Q · filed 2021-11-04 |
| 2021-06-30 | 497.19K shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 442.74K shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 193.94K shares 10-K · filed 2022-02-24 |
| 2020-09-30 | 224.53K shares 10-Q · filed 2020-11-05 |
| 2020-06-30 | 248.49K shares 10-Q · filed 2020-08-06 |
| 2020-03-31 | 248.49K shares 10-Q · filed 2020-05-07 |
| 2019-12-31 | 71.88K shares 10-K · filed 2021-02-26 |
| 2019-09-30 | 71.88K shares 10-Q · filed 2019-10-31 |
| 2019-06-30 | 72.61K shares 10-Q · filed 2019-08-01 |
| 2019-03-31 | 79.19K shares 10-Q · filed 2019-05-02 |
| 2018-12-31 | 109.07K shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 143.51K shares 10-Q · filed 2018-10-31 |
| 2018-06-30 | 261.04K shares 10-Q · filed 2018-08-01 |
| 2018-03-31 | 399.83K shares 10-Q · filed 2018-05-01 |
| 2017-12-31 | 479.82K shares 10-K · filed 2019-02-27 |
| 2017-09-30 | 765.64K shares 10-Q · filed 2017-10-31 |
| 2017-06-30 | 981.62K shares 10-Q · filed 2017-08-01 |
| 2017-03-31 | 1.17M shares 10-Q · filed 2017-05-02 |
| 2016-12-31 | 1.36M shares 10-K · filed 2018-03-14 |
| 2016-09-30 | 1.55M shares 10-Q · filed 2016-11-01 |
| 2016-06-30 | 1.76M shares 10-Q · filed 2016-08-04 |
| 2015-12-31 | 2.23M shares 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |